Sunee Sirivichayakul, Ph.D.
Principal Investigator of Vaccine and Cellular Immunology Laboratory
Chutitorn Ketloy, Ph.D.
Principal Investigator of Dengue Vaccine Research Unit
Chutitorn Ketloy received her Ph.D. from Chulalongkorn University (Biomedical Sciences). Currently, she is the assistant professor at Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University. For her research, she has been a research investigator at Chula Vaccine Research Center, Chula VRC since 2008. She served as a principal investigator and project coordinator in DNA-based dengue vaccine which has been evaluated in mice and non-human primates.
Siwaporn Boonyasuppayakorn, M.D., Ph.D.
Siwaporn Boonyasuppayakorn is a Virology lecturer of Department of Microbiology, Faculty of Medicine, Chulalongkorn University. After M.D. graduation in 2007, she began her research career with molecular and demographic analysis of respiratory syncytial virus infection under supervision of Associate Professor Parvapan Bhattarakosol, Ph.D. Her contribution included characterizing the novel lineage of genotype B in Thailand for the first time.
In 2009-2013, she continued her Ph.D. study with anti-dengue drug discovery and functional analysis of flaviviral enzymes under supervision of Professor Radhakrishnan Padmanabhan, Ph.D. in Georgetown University Medical Center, Washington, DC, USA. Her contributions included characterizing amodiaquine antimalarials as a dengue virus inhibitor and functional analysis of NS5 N- terminal domain for enzymatic activities. After graduation, she resumed her faculty position in Chulalongkorn University and continued working with anti-flaviviral drug discovery.
She started her independent research focusing on academic drug discovery. She and her team modified the classic plaque assay and equipped with automated quantification system using economical approach for medium-scale drug screening. Currently, she is characterizing drug candidates originated and modified from natural products for anti-dengue and Zika viruses using rational drug design.